Effect | Decrease |
Trial Design | Double blind |
Trial Length | n/a |
Number of Subjects | 170 |
Sex | n/a |
In primary insomnia patients, 2mg of prolonged release melatonin was effective in reducing sleep latency (time to sleep) and improving sleep quality without withdrawal effects.